Pharmacovigilance (PV) is a science relating to detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. To track Adverse Drug Reactions (ADRs) in Indian Population, Ministry of Health & Family Welfare (MoHFW), Government of India, has launched Pharmacovigilance Programme of India (PvPI). This programme has a pan-India outreach, but only a small proportion of the healthcare professionals have formal training on PV. As per the recent amendments to Drugs & Cosmetics (D&C) Rules, 1945, the inclusion of PV in undergraduate pharmacy curriculum as per Pharmacy Council of India (PCI) notification and order from MoHFW to all states/UTs Government regarding strengthening of PV in particular states, the avenues in PV sector have widened and it has become now a priority area. As per the theme of Pradhan Mantri Kaushal Vikas Yojana, IPC has taken initiative for skill development and capacity building programme by imparting training to young healthcare professionals in the field of Pharmacovigilance.
The pharmacist have tremendous role to the improvement of public health. With this conviction, IPA decide to develop Public-Private-Partnership (PPA) agreement initiated by Indian Pharmaceutical Association (IPA) and Central TB Division (CTBD) in 2006 to explore the potential of pharmacists for TB control programme. The association has now mooted another proposal with the CTBD to tap the potential of the retail pharmacists working in community pharmacies and hospital pharmacies.
.png)
